• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Minimal Residual Disease in Patients With Nonmetastatic Triple-Negative Breast Cancer: Positive, Negative, or a More Complex Issue?

作者信息

Davis Andrew A, Cristofanilli Massimo

机构信息

Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

出版信息

JAMA Oncol. 2020 Sep 1;6(9):1332-1333. doi: 10.1001/jamaoncol.2020.2285.

DOI:10.1001/jamaoncol.2020.2285
PMID:32644099
Abstract
摘要

相似文献

1
Minimal Residual Disease in Patients With Nonmetastatic Triple-Negative Breast Cancer: Positive, Negative, or a More Complex Issue?非转移性三阴性乳腺癌患者的微小残留病：阳性、阴性还是一个更复杂的问题？
JAMA Oncol. 2020 Sep 1;6(9):1332-1333. doi: 10.1001/jamaoncol.2020.2285.
2
Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer.I-III期三阴性乳腺癌新辅助化疗后的循环肿瘤细胞
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S552-8. doi: 10.1245/s10434-015-4600-6. Epub 2015 May 13.
3
Assessment of Residual Disease With Molecular Breast Imaging in Patients Undergoing Neoadjuvant Therapy: Association With Molecular Subtypes.新辅助治疗患者中分子乳腺成像对残余疾病的评估：与分子亚型的关联
Clin Breast Cancer. 2016 Oct;16(5):389-395. doi: 10.1016/j.clbc.2016.05.015. Epub 2016 May 14.
4
Tumor Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance.在三阴性乳腺癌新辅助铂类化疗期间发生的肿瘤逆转突变与治疗耐药相关。
Clin Cancer Res. 2017 Jul 1;23(13):3365-3370. doi: 10.1158/1078-0432.CCR-16-2174. Epub 2017 Jan 13.
5
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.分析化疗抵抗性三阴性乳腺癌复发的分子调控因子。
Breast Cancer Res. 2019 Aug 5;21(1):87. doi: 10.1186/s13058-019-1171-7.
6
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.BRCA 突变的三阴性乳腺癌患者的辅助化疗与新辅助化疗。
Breast Cancer Res Treat. 2018 Jul;170(1):101-109. doi: 10.1007/s10549-018-4727-9. Epub 2018 Feb 22.
7
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.三阴性乳腺癌新辅助化疗后残留肿瘤中肿瘤浸润性CD8 +和FOXP3 +淋巴细胞的预后意义及这些参数的变化：一项回顾性多中心研究
Breast Cancer Res. 2015 Sep 4;17(1):124. doi: 10.1186/s13058-015-0632-x.
8
CCR 20th Anniversary Commentary: Simpson's Paradox and Neoadjuvant Trials.CCR 20周年评论：辛普森悖论与新辅助试验
Clin Cancer Res. 2015 Sep 15;21(18):4027-9. doi: 10.1158/1078-0432.CCR-14-3124.
9
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.新辅助化疗后出现脉管侵犯与乳腺癌不良预后密切相关。
Breast Cancer Res Treat. 2018 Jun;169(2):295-304. doi: 10.1007/s10549-017-4610-0. Epub 2018 Jan 27.
10
Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy.新辅助化疗后三阴性乳腺癌的残余肿瘤负荷指数和肿瘤浸润淋巴细胞亚群。
Breast Cancer Res Treat. 2020 Jan;179(1):11-23. doi: 10.1007/s10549-019-05437-z. Epub 2019 Sep 16.

引用本文的文献

1
Knowledge-map and research trends of circulating tumor cells in breast cancer: a scientometric analysis.乳腺癌循环肿瘤细胞的知识图谱与研究趋势：一项科学计量学分析
Discov Oncol. 2024 Sep 28;15(1):506. doi: 10.1007/s12672-024-01385-3.
2
Distinct Prognosis of Minimal Residual Disease According to Breast Cancer Subtype in Patients with Breast or Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy.新辅助化疗后乳腺或淋巴结病理完全缓解患者中根据乳腺癌亚型不同微小残留病灶具有不同的预后。
Ann Surg Oncol. 2023 Nov;30(12):7060-7068. doi: 10.1245/s10434-023-13938-x. Epub 2023 Aug 3.